There are several forms of ACT, with the most prominent being CAR T-cell therapy. In this approach, T cells are genetically engineered to express chimeric antigen receptors (CARs) that target specific proteins on cancer cells. Once reinfused, these modified T cells can recognize and destroy cancer cells more effectively.
